Hepatitis E virus ‐associated Guillain–Barre syndrome: Revision of the literature
ConclusionsAn overview of possible pathogenesis will gain a first insight into why HEV, traditionally recognized as only hepatotropic, can induce many neurological disorders represented by GBS. Moreover, understanding of the underlying mechanisms may contribute to development of a novel therapeutic strategy. This review also summarizes management and clinical characteristics of HEV ‐associated GBS, aiming to achieve early recognition and good recovery.
Source: Brain and Behavior - Category: Neurology Authors: Hang Liu,
Ying Ma Tags: REVIEW Source Type: research
More News: Antiviral Therapy | Autoimmune Disease | Bangladesh Health | Brain | Endemics | Guillain-Barr Syndrome | Hepatitis | Immunotherapy | Netherlands Health | Neurology | Study